Price (delayed)
$2.17
Market cap
$106.43M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.21
Enterprise value
$64.35M
MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S.
There are no recent dividends present for MNOV.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.